Literature DB >> 15276408

Evaluation of DNA damage in patients with arsenic poisoning: urinary 8-hydroxydeoxyguanine.

Hiroshi Yamauchi1, Yoshito Aminaka, Katsumi Yoshida, Guifan Sun, Jingbo Pi, Michael P Waalkes.   

Abstract

The relationship between arsenic exposure and DNA damage in patients with acute or chronic arsenic poisoning was analyzed. Urinary 8-hydroxydeoxyguanine (8-OHdG) concentrations were measured as an indication of oxidative DNA damage. A remarkable increase in 8-OHdG in the urine was observed in 60% of 52 patients with acute arsenic poisoning from the accidental oral intake of the arsenic trioxide. This was two- to threefold higher than levels in normal healthy subjects (n = 248). There was a clear relationship between arsenic concentrations in urine after acute poisoning and elevated levels of 8-OHdG. Levels of urinary 8-OHdG returned to normal within 180 days after the acute arsenic poisoning event. In patients chronically poisoned by the consumption of well water with elevated levels of arsenate [As(V)], elevated 8-OHdG concentrations in urine were also observed. A significant correlation between the 8-OHdG levels and arsenic levels in the urine was observed in 82 patients with chronic poisoning. Thus, evidence of oxidative DNA damage occurred in acute arsenic poisoning by arsenite [As(III)] and in chronic arsenic poisoning by As(V). In chronic poisoning patients provided low-arsenic drinking water, evidence of DNA damage subsided between 9 months and 1 year after the high levels of arsenic intake were reduced. The initial level of arsenic exposure appeared to dictate the length of this recovery period. These data indicate that some aspects of chronic and acute arsenic poisoning may be reversible with the cessation of exposure. This knowledge may contribute to our understanding of the risk elevation from arsenic carcinogenesis and perhaps be used in a prospective fashion to assess individual risk.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15276408     DOI: 10.1016/j.taap.2003.10.021

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  20 in total

1.  Comparing the relative oxidative DNA damage caused by various arsenic species by quantifying urinary levels of 8-hydroxy-2'-deoxyguanosine with isotope-dilution liquid chromatography/mass spectrometry.

Authors:  Jin-Zhu Wu; Paul C Ho
Journal:  Pharm Res       Date:  2009-03-06       Impact factor: 4.200

2.  A dose-response study of arsenic exposure and markers of oxidative damage in Bangladesh.

Authors:  Kristin N Harper; Xinhua Liu; Megan N Hall; Vesna Ilievski; Julie Oka; Larissa Calancie; Vesna Slavkovich; Diane Levy; Abu Siddique; Shafiul Alam; Jacob L Mey; Alexander van Geen; Joseph H Graziano; Mary V Gamble
Journal:  J Occup Environ Med       Date:  2014-06       Impact factor: 2.162

3.  Arsenic transformation predisposes human skin keratinocytes to UV-induced DNA damage yet enhances their survival apparently by diminishing oxidant response.

Authors:  Yang Sun; Chikara Kojima; Colin Chignell; Ronald Mason; Michael P Waalkes
Journal:  Toxicol Appl Pharmacol       Date:  2011-07-21       Impact factor: 4.219

4.  p16INK4a reporter mice reveal age-promoting effects of environmental toxicants.

Authors:  Jessica A Sorrentino; Janakiraman Krishnamurthy; Stephen Tilley; James G Alb; Christin E Burd; Norman E Sharpless
Journal:  J Clin Invest       Date:  2013-12-16       Impact factor: 14.808

5.  The ATP-binding cassette transporter ABCB6 is induced by arsenic and protects against arsenic cytotoxicity.

Authors:  Hemantkumar Chavan; Mahitha Oruganti; Partha Krishnamurthy
Journal:  Toxicol Sci       Date:  2011-01-25       Impact factor: 4.849

6.  Requirement of arsenic biomethylation for oxidative DNA damage.

Authors:  Chikara Kojima; Dario C Ramirez; Erik J Tokar; Seiichiro Himeno; Zuzana Drobná; Miroslav Stýblo; Ronald P Mason; Michael P Waalkes
Journal:  J Natl Cancer Inst       Date:  2009-12-16       Impact factor: 13.506

7.  Persistence of DNA damage following exposure of human bladder cells to chronic monomethylarsonous acid.

Authors:  S M Wnek; M K Medeiros; K E Eblin; A J Gandolfi
Journal:  Toxicol Appl Pharmacol       Date:  2009-08-20       Impact factor: 4.219

8.  Baseline comorbidities in a skin cancer prevention trial in Bangladesh.

Authors:  Maria Argos; Mahfuzar Rahman; Faruque Parvez; James Dignam; Tariqul Islam; Iftekhar Quasem; Samar K Hore; Ahmed T Haider; Zahid Hossain; Tazul I Patwary; Muhammad Rakibuz-Zaman; Golam Sarwar; Paul La Porte; Judith Harjes; Kristen Anton; Muhammad G Kibriya; Farzana Jasmine; Rashed Khan; Mohammed Kamal; Christopher R Shea; Muhammad Yunus; John A Baron; Habibul Ahsan
Journal:  Eur J Clin Invest       Date:  2013-04-17       Impact factor: 4.686

9.  Biomarkers of arsenic exposure and effects in a Canadian rural population exposed through groundwater consumption.

Authors:  Louise Normandin; Pierre Ayotte; Patrick Levallois; Yves Ibanez; Marilène Courteau; Greg Kennedy; Lydia Chen; X Chris Le; Michèle Bouchard
Journal:  J Expo Sci Environ Epidemiol       Date:  2013-11-06       Impact factor: 5.563

10.  Arsenic-induced malignant transformation of human keratinocytes: involvement of Nrf2.

Authors:  Jingbo Pi; Bhalchandra A Diwan; Yang Sun; Jie Liu; Wei Qu; Yuying He; Miroslav Styblo; Michael P Waalkes
Journal:  Free Radic Biol Med       Date:  2008-06-03       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.